XTalks

AUGUST 30, 2022

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. CNS drugs treat a range of neurologic and psychiatric disorders, such as psychosis, depression, Parkinson’s disease, multiple sclerosis and epilepsy.

Trials 83

Trials Drug Delivery Drugs Gene 83

Roots Analysis

MARCH 16, 2022

In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Broad Clinical Trial Landscape.

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. These include broad-spectrum sunscreens, protective clothing and innovative skincare products developed using antioxidants and other protective agents. How is Medicus Pharma innovating in this space?

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

STAT News

NOVEMBER 3, 2022

The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing The single-dose vaccine candidate is a combination of Pfizer’s mRNA-based flu shot and the Omicron-tailored Covid-19 booster shot developed by both companies.

Vaccination 97

Vaccination Vaccine Drug Delivery Systems Sales 97

Roots Analysis

MARCH 2, 2022

Interestingly, recent advances in this domain have led to the development of several treatment strategies that, according to developers, exhibit the necessary capabilities to overcome challenges posed by traditional oral protein formulations and peptide-based therapies. Oral Protein / Peptide-based Drugs.

Protein 52

Protein Drug Delivery Drugs Drug Delivery Systems 52

Drug Discovery World

JUNE 7, 2023

The additional investment will support growth of the company’s proprietary RALA platform with an immediate focus on the advancement of pHion’s lead project, PTX_V1, into clinical trials in the first half of 2024. PTX_V1 is a first-in-class therapeutic vaccine for the treatment of human papilloma virus (HPV)-related cancers.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

Roots Analysis

MAY 21, 2024

Amidst the ongoing initiatives to develop therapeutic interventions with improved bioavailability, lipid nanoparticle (LNPs) have specifically attracted the attention of researchers and drug developers. Further, they have been extensively utilized in the development of mRNA vaccines for COVID-19.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40

Drug Discovery World

OCTOBER 19, 2022

Ashley Rein , Global Market Manager for Topical Drug Delivery at Lubrizol Life Science Health (LLS Health), explains how by using mucoadhesive drug delivery, developers can bring novel drugs to market and maximise the efficacy of pre-existing APIs. . Consider drug delivery systems early on .

Drug Delivery 52

Drug Delivery Drugs Drug Delivery Systems Development 52

Pharmaceutical Technology

NOVEMBER 7, 2022

SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. The Charleston Regional Development Alliance (CRDA) is supporting SHL Medical by facilitating valuable connections to best-in-class service providers in the area.

Production 130

Production Life Science Manufacturing Drug Delivery Systems 130

XTalks

MAY 30, 2023

The VTT Technical Research Centre of Finland has addressed this issue by developing a fully recyclable, modular ECG patch constructed from VTT’s novel cellulose e-skin material. There are also several ECG patches currently in clinical trials that could soon enter the market. How Can VTT’s ECG Patch Impact the Healthcare Industry?

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Roots Analysis

FEBRUARY 18, 2022

The key focus of these studies is on the development of anti-tumor therapeutics. CLINICAL TRIALS EVALUATING MYELOID CELLS TAREGTING THERAPEUTICS. In the past decade, more than 1,500 clinical trials have been registered for evaluating drug therapies targeting myeloid cells. Our Social Media Platform. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

MARCH 3, 2022

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Currently, nine complement therapeutics are commercially available, while around 190 molecules are under development for various disease indications. Broad Clinical Trial Landscape. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

Roots Analysis

SEPTEMBER 1, 2023

The integration of the blue ocean strategy in healthcare landscape, often known as blue ocean therapy, and its application in medical product development, such as blue ocean medical products, is the silver lining that can revolutionize the industry. This strategy is not a silver bullet; it’s a calculated voyage into uncharted waters.

Drug Delivery 52

Drug Delivery Marketing Drug Delivery Systems Drugs 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The requirements are moving in the direction of testing the full system,” explains Santambrogio.

Contamination 130

Contamination Packaging Packaging Manufacturing 130

Delveinsight

NOVEMBER 29, 2020

Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. Looking at its potential, the drug is also being watched out in diabetic macular edema in combination with intravitreal anti-VEGF drugs.

Marketing 52

Marketing Pharma Companies Drug Delivery Clinical Trials 52

The Pharma Data

AUGUST 31, 2021

Vice President, Late Development and Global Medical Affairs, Janssen Research & Development, LLC. “We Prostate-Specific AntigenKinetics in Patients from TITAN and SPARTAN (oral presentation): Post-hoc analysis of PSA kinetics in 1,331 patients treated with ERLEADA ® from both the TITAN and SPARTAN trials (Abstract #PD34-11).

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Trials Drugs 52